$Relapsed or Refractory Metastatic CRC$

Relapsed or Refractory Metastatic CRC

Episodes

Specialty:

All

Year:

All

EP. 1: Continuum of Care in Metastatic Colorectal Cancer

February 25th 2020

EP. 2: Initial Systemic Therapy for Metastatic Colorectal Cancer

February 25th 2020

EP. 3: Molecular Status and Subsequent Therapies in mCRC

February 25th 2020

EP. 4: Role of Rebiopsy and ctDNA Testing at Progression of mCRC

February 25th 2020

EP. 5: Third-line and Later-line Therapies in R/R mCRC

February 25th 2020

EP. 6: R/R Metastatic CRC: CORRECT, IMblaze370, and ReDOS Trials

February 25th 2020

EP. 7: Management of R/R mCRC: Sequencing for Later-Line Therapies

February 25th 2020

EP. 8: Relapsed/Refractory mCRC: Immunotherapy in MSI-High Tumors

February 25th 2020

EP. 9: Role of Immunotherapy in Microsatellite-Stable R/R mCRC

February 25th 2020

EP. 10: Future Directions for Later-Line Therapy in R/R mCRC

February 25th 2020

Trending on OncLive

Epcoritamab Plus R-CHOP Meets PFS End Point in Newly Diagnosed DLBCL

‘Our Impact Will Be Broad and Transformative’: Wells Messersmith, MD, Takes the Reins at CU Anschutz Cancer Center

FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL

Berzosertib Plus Carboplatin Fails to Improve Responses in Pretreated mCRPC

Botensilimab Plus Balstilimab Yields Durable OS in Recurrent Ovarian Cancer